白云山A三季赚2.1亿同增25% 四因素牵制医药企业发展
白云山A三季赚2.1亿同增25% 四因素牵制医药企业发展: 白云山A相关负责人在接受记者采访时表示，第三季度是整个行业的艰难时期，遭遇了银根收紧、人工和采购成本上升、基本药物招标模式变化、抗生素分级管理办法出台，这四大因素对业绩增长有一定牵制作用。 ...
A brutal elimination round is reshaping the world's biggest market for electric cars
Chinese EV makers showing off their newest models at Auto China , which kicks off in Beijing have enjoyed generous support from the ... View article...